EP Patent

EP1980255A1 — Pharmaceutical compositions containing synthetic steroid derivatives such as tibolone, minerals such as calcium and the active metabolite of vitamin d (calcitrol) for the prevention and treatment of osteoporosis and menopause

Assigned to World Trade Import Export Wtie AG · Expires 2008-10-15 · 18y expired

What this patent protects

The present invention generally relates to pharmaceutical industry and, in particular, to drug preparer pharmaceutical industry for controlling osteoporosis. More specifically, the present invention relates to a combination comprising a combination of a synthetic steroid derivati…

USPTO Abstract

The present invention generally relates to pharmaceutical industry and, in particular, to drug preparer pharmaceutical industry for controlling osteoporosis. More specifically, the present invention relates to a combination comprising a combination of a synthetic steroid derivative such as Tibolone, minerals such as calcium and the active metabolite of vitamin D 1,25(OH) 2 (calcitrol) for the prevention and treatment of osteoporosis. The inventive composition is advantageous over the prior art in that the same results can be obtained with a smaller amount of each of the components than when they are consumed separately or better results can be obtained with the same amount of each of the components than when they are consumed separately. Said composition consists of: a synergistic combination of a synthetic steroid, minerals and the active metabolite of vitamin D, 1,25 (OH)2 D3 (calcitrol) for the prevention and treatment of osteoporosis.

Drugs covered by this patent

Patent Metadata

Patent number
EP1980255A1
Jurisdiction
EP
Classification
Expires
2008-10-15
Drug substance claim
No
Drug product claim
No
Assignee
World Trade Import Export Wtie AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.